Sign Up Today and Learn More About Nirmidas Biotech Stock
Invest in or calculate the value of your shares in Nirmidas Biotech or other pre-IPO companies through EquityZen's platform.
Nirmidas Biotech Stock (NIBI)
Nirmidas provides innovative solutions
About Nirmidas Biotech Stock
Founded
2013
Headquarters
San Francisco, CA, US
Total Funding
7.0M
Industries
Software, Artificial Intelligence, Financial Services
Nirmidas Biotech Press Mentions
Stay in the know about the latest news on Nirmidas Biotech
New saliva-based lateral-flow antibody test platform for assessing infections …
patents • Feb 16, 2025
Assays, sensing platforms, and methods for diagnosis of coronavirus infection …
patents • Feb 16, 2025
FDA authorizes fingerstick COVID-19 antibody test
massdevice • Jan 09, 2021
Regulatory actions for Jan. 5, 2021
bioworld • Jan 06, 2021
Nirmidas Biotech Management
Leadership team at Nirmidas Biotech
Co-founder - CEO
Meijie Tang
Co-Founder
Hongjie Dai
Join now and verify your accreditation status to gain access to:
- Nirmidas Biotech Current Valuation
- Nirmidas Biotech Stock Price
- Nirmidas Biotech Management
- Available deals in Nirmidas Biotech and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Nirmidas Biotech Cap Table and Funding History by Share Class and Liquidity Preferences
- Nirmidas Biotech Revenue and Financials
- Nirmidas Biotech Highlights
- Nirmidas Biotech Business Model
- Nirmidas Biotech Risk Factors
- Nirmidas Biotech Research Report from SACRA Research
Trading Nirmidas Biotech Stock
How to invest in Nirmidas Biotech stock?
Accredited investors can buy pre-IPO stock in companies like Nirmidas Biotech through EquityZen funds. These investments are made available by existing Nirmidas Biotech shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Nirmidas Biotech stock?
Shareholders can sell their Nirmidas Biotech stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
